Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery

Abstract

The interaction of nanoparticles with a range of biomolecules once they have been injected within the body can affect their performance. Here, the authors demonstrate that squalene nanomaterials conjugated with anticancer drugs can interact with lipoproteins and can be used to target cancer cells.